Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

ADAMTS13 recovery in acute thrombotic thrombocytopenic purpura after caplacizumab therapy

Blood (2024) 143 (18): 1807–1815.

https://doi.org/10.1182/blood.2023022725

Published: 2024

Includes: Supplemental data

Journal Articles

Impact of Age on Hemostasis of Patients with Immune Thrombocytopenia

Elena Monzón Manzano, Maria Teresa Álvarez-Roman, Paula Acuña, Elena G Arias-Salgado, Raquel Ramírez Martín, Maria Cristina Pascual Izquierdo, Maria Isabel Rivas Pollmar, Monica Martin Salces, Waleed Ghanima, Víctor Jiménez-Yuste, Nora Butta

Blood (2023) 142 (Supplement 1): 1211.

https://doi.org/10.1182/blood-2023-185706

Published: 2023

Journal Articles

Caplacizumab Frontline Added to Therapeutic Plasma Exchange and Immunosuppression Prevents Unfavorable Outcomes in Immune-Mediated TTP: An International Real-World Study of the TTP-IWG (The Capla 500 Project)

Blood (2023) 142 (Supplement 1): 2636.

https://doi.org/10.1182/blood-2023-179316

Published: 2023

Journal Articles

A Real-World Analysis of Immune Thrombotic Thrombocytopenic Purpura: Comparing Clinical Outcomes of Conventional Treatment Vs Addition of Caplacizumab, a Single-Center Experience

Valeria Estefania Delgado Pinos, Pilar Lancho Lavilla, Marta Moreno Carbonell, Ana Pérez Corral, Cristina Pascual Izquierdo

Blood (2023) 142 (Supplement 1): 2634.

https://doi.org/10.1182/blood-2023-190922

Published: 2023

Journal Articles

Caplacizumab Treatment in Elderly Patients with iTTP: Updated Experience from the Spanish TTP Registry

Blood (2023) 142 (Supplement 1): 5429.

https://doi.org/10.1182/blood-2023-180970

Published: 2023

Journal Articles

Avatrombopag in Immune Thrombocytopenia (ITP). Real-Life Experience of Its Use in Hospitals within the Community of Madrid, Spain (AVAMAD STUDY)

María José Llácer Ferrandis, Silvia Monsalvo Saornil, Almudena De Laiglesia, Celia Martínez Vázquez, María Menor Gómez, Esther Chica Gullón, Gloria Pérez Segura, Nuria Revilla, Teresa Arquero, Ariana Ortúzar Pasalodos, Maria Teresa Alvarez Roman, Isabel González-Gascón, Gemma Moreno Jiménez, Cristina Pascual Izquierdo

Blood (2023) 142 (Supplement 1): 3961.

https://doi.org/10.1182/blood-2023-186292

Published: 2023

Journal Articles

Pttapp: An Application Developed By the Spanish Society of Hematology and Hemotherapy to Show Practical Recommendations on the Management of Immune TTP

Maria Eva Mingot-Castellano, Rosa Goterris, Moraima Jiménez, Valle Recasens, Saioa Zalba, Marta Fernandez-Docampo, Ana Kerguelen Fuentes, Jose Garcia-Arroba, Inés Gómez-Seguí, David Valcárcel, Cristina Pascual Izquierdo

Blood (2022) 140 (Supplement 1): 5011–5012.

https://doi.org/10.1182/blood-2022-162499

Published: 2022

Journal Articles

Acquired Factor XIII Deficiency Is Associated with High Morbidity and Mortality in Critically Ill Patients

Miguel López Esteban, Marta Moreno Carbonell, Jesus Viñas Soler, Jose L. Diez Martin, Patricia Duque, Cristina Pascual Izquierdo

Blood (2022) 140 (Supplement 1): 1422–1424.

https://doi.org/10.1182/blood-2022-170330

Published: 2022

Journal Articles

Idarucizumab for Reversal of Dabigatran: Multicenter Real-World Experience

Paola Alejandra Barzallo Burbano, Mar Meijón, Nuria Revilla Calvo, María Jesús Blanco Bañares, Begoña Fernández, Ramón Rodríguez-González, María Elena Sola Aparicio, Belén Rosado Sierra, Susana Asenjo Correa, Isabel Gutiérrez, María Pilar Llamas Sillero, José L. Díez-Martín, Gloria Pérez-Rus, Cristina Pascual Izquierdo

Blood (2021) 138 (Supplement 1): 2134.

https://doi.org/10.1182/blood-2021-152962

Published: 2021

Journal Articles

Caplacizumab As New Paradigm-Changing Therapy for Patients with Autoimmune Thrombotic Thrombocytopenic Purpura (aTTP): Real-World Data from TTP Spanish Registry

Blood (2020) 136 (Supplement 1): 20–21.

https://doi.org/10.1182/blood-2020-136627

Published: 2020

Journal Articles

Impact of Sars-CoV2 Infection on 491 Hematological Patients: The Ecovidehe Multicenter Study

Cristina De Ramón, Jose Angel Hernandez-Rivas, MD PhD, Jose Antonio Rodríguez García, Enrique M. Ocio, MDPhD, María Teresa Gómez-Casares, MD PhD, Javier López Jiménez, MD PhD, Carlos Solano, MD PhD, Joaquín Martínez-López, Anna Sureda, Manuel Jurado, MD PhD, Raul Córdoba, MD PhD, Celina Benavente, Pascual Marco, Jose Antonio Pérez-Simón, MD, Jose Maria Moraleda, MD PhD, Angela Figuera, Emilia Pardal, Cristina Pascual Izquierdo, PhD MD, Ramon Garcia-Sanz

Blood (2020) 136 (Supplement 1): 5–6.

https://doi.org/10.1182/blood-2020-142292

Published: 2020

Journal Articles

COVID-19 Associated Coagulopathy: A Comprehensive Assessment of the Coagulation Profile in Critically and Non-Critically Ill Patients

Reyes María Martín-Rojas, MD, Maite Chasco, MD, Sara Casanova, MD, Valeria Estefanía Delgado-Pinos, MD, Gloria Perez-Rus, MD PhD, Patricia Duque, MD, Milagros Sancho, MD, Jose L. Diez-Martin, MD PhD, Cristina Pascual Izquierdo, PhD MD

Blood (2020) 136 (Supplement 1): 5.

https://doi.org/10.1182/blood-2020-138882

Published: 2020

Journal Articles

Long Term Discontinuation of Eltrombopag after Remission in Primary Immune Thrombocytopenia: 8-Year Follow-up Data from 15 Spanish Centers

Tomas Jose Gonzalez-Lopez, Fernando Fernandez-Fuertes, Maria Cristina Pascual Izquierdo, PhD MD, Isabel Caparros, Silvia Bernat, Carmen Pastoriza, Maria Paz Martínez-Badas, Pável E Olivera, MD, Gonzalo Caballero, MD, Jose Angel Hernandez-Rivas, MD PhD, Daniel Martínez-Carballeira, MD, Inmaculada Soto Ortega, Gloria Perez Segura, Isabel Regalado, Blanca Sánchez-González, Isidro Jarque, Luis Javier garcia Frade, MD, Miguel A. Sanz

Blood (2019) 134 (Supplement_1): 2352.

https://doi.org/10.1182/blood-2019-129274

Published: 2019

Journal Articles

Incidence, Diagnosis, and Outcome of Acquired Thrombotic Thrombocytopenic Purpura (aTTP): A Nationwide Survey By the Spanish Apheresis Group

Maria Cristina Pascual Izquierdo, PhD MD, Julio Del Rio-Garma, MD, Javier De La Rubia, Aurora Viejo, MD, Jesus Fernandez-Sojo, MD, Jesus Martin, MD, Xavier Solanich, MD, Faustino García-Candel, PhD MD, Luis Hernandez, MD, Marta Fernandez, MD, Ana Oliva, MD, Jose Maria Garcia-Gala, MD, Maria Eva Mingot-Castellano, PhD MD, Ines Gomez-Seguí, MD PhD, Rosa Goterris, MD, Michael Calviño, MD, María Luisa Antelo, MD PhD, Sol Sanchez, MD, Jose Antonio Moreno, MD, Cristina Amunarriz, MD, Jose Garcia-Arroba, MD, Carmen Fernandez, MD, Nieves Alonso, MD, Victoria Gonzalez, MD, Luisa Guerra, MD, M. Elena Moreno, MD, Moreno M. Dolores, MD, Gemma Moreno, MD, Melisa Daorta, MD, Esther Chica, MD, Rafael Del Orbe, MD PhD, Joan Cid, MD PhD, Margarita Berberana, MD, Carmen Ballester, MD, Sara Nistal Gil, MD, Julia Vidan, MD, Maite Calderon, MD, Consuelo Martinez Redondo, MD, Jose Carlos Hernandez, MD, Marina Gordillo, MD, Angel Salgado, Ramon Salinas, MD PhD

Blood (2019) 134 (Supplement_1): 4910.

https://doi.org/10.1182/blood-2019-123258

Published: 2019

Journal Articles

Factors Associated with Mortality in Patients Experiencing First Episodes of Acquired Thrombotic Thrombocytopenic Purpura (aTTP). Results of the Spanish TTP Registry

Blood (2019) 134 (Supplement_1): 1082.

https://doi.org/10.1182/blood-2019-122665

Published: 2019

Journal Articles

(AVK) Anti Vitamin K Treatment In patients with Fontan Surgery

Maria Stefania Infante, Cristina Pascual Izquierdo, Fernando Carretero Lopez, Jose Manuel Sanchez Ramirez, Ana Maria Rodriguez Huerta, Gloria Perez Rus and Jose Luis Diez Martin

Blood (2010) 116 (21): 4397.

https://doi.org/10.1182/blood.V116.21.4397.4397

Published: 2010

NARROW

ADAMTS13 recovery in acute thrombotic thrombocytopenic purpura after caplacizumab therapy

Impact of Age on Hemostasis of Patients with Immune Thrombocytopenia

Caplacizumab Frontline Added to Therapeutic Plasma Exchange and Immunosuppression Prevents Unfavorable Outcomes in Immune-Mediated TTP: An International Real-World Study of the TTP-IWG (The Capla 500 Project)

A Real-World Analysis of Immune Thrombotic Thrombocytopenic Purpura: Comparing Clinical Outcomes of Conventional Treatment Vs Addition of Caplacizumab, a Single-Center Experience

Caplacizumab Treatment in Elderly Patients with iTTP: Updated Experience from the Spanish TTP Registry

Avatrombopag in Immune Thrombocytopenia (ITP). Real-Life Experience of Its Use in Hospitals within the Community of Madrid, Spain (AVAMAD STUDY)

Pttapp: An Application Developed By the Spanish Society of Hematology and Hemotherapy to Show Practical Recommendations on the Management of Immune TTP

Acquired Factor XIII Deficiency Is Associated with High Morbidity and Mortality in Critically Ill Patients

Idarucizumab for Reversal of Dabigatran: Multicenter Real-World Experience

Caplacizumab As New Paradigm-Changing Therapy for Patients with Autoimmune Thrombotic Thrombocytopenic Purpura (aTTP): Real-World Data from TTP Spanish Registry

Impact of Sars-CoV2 Infection on 491 Hematological Patients: The Ecovidehe Multicenter Study

COVID-19 Associated Coagulopathy: A Comprehensive Assessment of the Coagulation Profile in Critically and Non-Critically Ill Patients

Long Term Discontinuation of Eltrombopag after Remission in Primary Immune Thrombocytopenia: 8-Year Follow-up Data from 15 Spanish Centers

Incidence, Diagnosis, and Outcome of Acquired Thrombotic Thrombocytopenic Purpura (aTTP): A Nationwide Survey By the Spanish Apheresis Group

Factors Associated with Mortality in Patients Experiencing First Episodes of Acquired Thrombotic Thrombocytopenic Purpura (aTTP). Results of the Spanish TTP Registry

(AVK) Anti Vitamin K Treatment In patients with Fontan Surgery

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only